Navigation Links
Narconon Releases Report on its Very First Narconon Program, the First of 23 Reviews or Evaluations of Results up to 2009
Date:5/21/2013

s a book in the prison library by humanitarian and philosopher L. Ron Hubbard, called Scientology - Fundamentals of Thought. Reading that book, Benitez later wrote, “I found that if a person rehabilitated and applied certain abilities, that person could persevere toward goals set, confront life, isolate problems and resolve them, communicate with life, be responsible and set ethical standards, and function within the band of certainty.” Pretty high flying thoughts for an inmate struggling to free himself from addiction. But that was the beginning of what developed into the international Narconon life skills program, now with 13 rehab centers in the U.S. and 51 worldwide.

“We had so few books in that first class,” recalls Gordie, “that we cut them up into chapter booklets. Everyone took one chapter back to his cell to read. Then we would talk about them, and so on.”

That first class was just discussion and doing the same communication drills or exercises which beginning Narconon students do even today as one of the current eight steps of the program. They also got lectures from Peter Green, a volunteer who came in to help once a month.

“Prison was and still is just ‘routine,’ “ says Gordie. “There’s breakfast, your cell. Lunch, your cell. No thought of the future. But when I got involved with Narconon, it opened me up -- I started to feel good, more competent. I was getting help, but helping myself. Getting stronger and developing abilities to confront life.”

As early as August 1966, the Narconon program had started receiving attention with its first coverage by The Arizona Star. “There is nothing Benitez doesn’t know about dope,” the article quotes Warden Eyman as saying, but then continues that Benitez along with 20 inmates was “trying to kick the habit and then help other addicts to do likewise.” By 1971 the still new Narconon program began to garner further praise for its drug-free and crime-free results. The

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Narconon Louisiana Supports United Nations International Day Against Drug Abuse and Illicit Trafficking
2. Mary Rieser of Narconon Georgia Speaks Out For United Nations International Day Against Drug Abuse
3. Narconon Arrowhead Celebrates Twenty Years of Service to More than Ten Thousand Recovering Addicts
4. Narconon Offers New Tool to Help Families Find Faster Solutions to Addiction
5. Narconon Arrowhead Welcomes International Drug Prevention Specialist Who Brings Message of Hope to Clients
6. Narconon International Pledges Wholehearted Support for Rx Drug Abuse Summit Cause: “Make an Impact”
7. International Narconon Directors Join Parents of Graduates to Celebrate Release of 40 Years of Positive Outcome Studies
8. Narconon Arrowhead Volunteers Provide Enthusiastic Support for Pride in McAlester Celebration
9. Narconon Arrowhead Welcomes Worldwide Management Staff for Inspirational Tour
10. LAPD Singles Out Narconon Drug Prevention and Education for Special Commendation
11. Recent Release of ‘The Narconon Program - 40 Years of Evidence of Recovery’ Reveals Earlier Unfound Narconon Connecticut Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... , ... Dental clinicians from Newcastle University, United Kingdom, visited ... more about its integrated approach to diabetes care. , Philip Preshaw, BDS, PhD, ... at Newcastle University, and Susan Bissett, National Institute for Health Research Clinical Research ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... registration for the company’s second Introduction to Hyperbaric Medicine Course. The next UHMS ... aboard the Queen Mary Hotel in Long Beach, CA. The meeting is open ...
(Date:8/31/2015)... ... 2015 , ... CareSource, a nonprofit Ohio-based health plan, has ... Michael will provide strategic leadership for CareSource’s marketing, branding, corporate communications and media ... contributed to the company’s rapid growth. As the CareSource business model expands to ...
(Date:8/31/2015)... ... August 31, 2015 , ... In an article published ... Reconstructive Surgery Global Open Journal that discusses the future of 3-D printing technology as ... the future, customized implants, prosthetics, and other 3-D printed tools could be used to ...
(Date:8/31/2015)... NJ (PRWEB) , ... August 31, 2015 , ... NJ Top Docs Presents, Dr. Michael ... and raised in Park Ridge, New Jersey, Dr. Michael Betsy graduated from Don Bosco Prep ... hockey and served as team captain in both sports in his senior year. He ...
Breaking Medicine News(10 mins):Health News:Western Diabetes Institute Collaborates with UK team 2Health News:Western Diabetes Institute Collaborates with UK team 3Health News:Western Diabetes Institute Collaborates with UK team 4Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 2Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 3Health News:Registration Opens for Wound Care Advantage’s Second UHMS Approved 40-Hour Introduction to Hyperbaric Medicine Course 4Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 2Health News:Recent Article on 3-D Printing Highlights the Future of Custom Medical Solutions Using the Technology, says Beverly Hills Physicians 3Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3
... to maximize a ... woman,s chance for survival., EVERGREEN PARK, Ill., Nov. 16 In ... to,the American Cancer Society. Breast cancer is the most common cancer among,women, ... cancer,death in women, after lung cancer. Little Company of Mary Hospital ...
... Republic of Georgia Drug Agency Approves Protocol for New ... of Bavituximab in Combination ... Peregrine,Pharmaceuticals, Inc. (Nasdaq: PPHM ), a clinical stage ... and,hepatitis C virus (HCV) infection, today announced that its ...
... ANGELES, Nov. 16 Neutrogena(R), a worldwide leader,in ... announced today that actress Diane Lane has signed ... Ms. Lane is a captivating and inspiring actress ... and daring spirit. In her new,role, she will ...
... antiemetic pharmaceutical drug (suitable for control of vomiting), ... This was the conclusion of clinical tests undertaken ... the results of which have been recently published ... The Oncologist . , Granisetrn is a ...
... Vaccine Efforts Stumble, Millions Remain Without AIDS Treatment ... ... time in,two weeks, clinical researchers working to develop an AIDS vaccine have,announced ... failed -- after Merck,s AIDS vaccine trial was halted last week,when its ...
... new alternative for patients with erosive gastroesophageal reflux disease ... (GERD) who cannot ... division of Wyeth (NYSE: WYE ), announced today that ... For Delayed-Release Oral Suspension, a new addition,to the Protonix family ...
Cached Medicine News:Health News:Web Site Helps Women Evaluate Risk of Breast Cancer 2Health News:Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 2Health News:Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 3Health News:Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer 4Health News:Oscar-Nominated Actress Signs on as Neutrogena(R) Brand Ambassador 2Health News:Subcutaneous administration of an antiemetic for treating vomiting caused by chemotherapy 2Health News:AIDS Vaccine Failures Highlight Need to Focus on Lifesaving Treatment, Says AHF 2Health News:Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension 2Health News:Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension 3
(Date:8/31/2015)...  Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX ), a ... of Locilex® (pexiganan cream 0.8%), a novel, broad spectrum, ... four investor conferences in September. , ... Company, LLC Emerging Growth Conference in ... , President & Chief Executive Officer, will present a ...
(Date:8/31/2015)... Israel , August 31, 2015 ... (TASE: BOLT, OTCQX: BLGTY) ("BioLight" or the ... commercializes biomedical innovations in ophthalmology and cancer diagnostics, ... Technologies (TASE: MCTC), has identified several new genetic ... the jawbone in patients treated with bisphosphonate drugs ...
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Asterias ... focused on the emerging field of regenerative medicine, ... dosed at Chicago -based Rush ... trial evaluating activity of escalating doses of AST-OPC1 ... sensory and motor complete cervical spinal cord injury ...
Breaking Medicine Technology:Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 2Dipexium Pharmaceuticals Announces Participation in Four Investor Conferences in September 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 2BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 3BioLight Reports Positive Clinical Study Results for Identifying New Genetic Markers to Predict Risk of Developing BRONJ 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 4Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 5Asterias Biotherapeutics Concludes Recruitment of Initial Safety Cohort of the SCiStar Phase 1/2a Dose-Escalation Clinical Trial of AST-OPC1 for Complete Cervical Spinal Cord Injury 6
... , NEW YORK ... (Sony) announced today that it has acquired iCyt Mission Technology, Inc. ... cell and disease research, through its U.S. subsidiary, Sony Corporation of ... technologies to enter the flow cytometry business in the life science ...
... , Feb. 9 STD Med, Inc., a manufacturer ... is pleased to announce the acquisition of a new 32,000 sq. ... addition to the current footprint of 120,000 sq. ft. "We are ... financial times," said Steven Tallarida , President STD Med, "we ...
Cached Medicine Technology:Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt 2Sony Enters the Flow Cytometry Business in Life Science Field by Acquiring iCyt 3STD Med Inc. Acquires Facility for Manufacturing and Start-Ups 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: